A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer.
(Q40330401)
scientific article published on 27 April 2006
scientific article published on 27 April 2006
Language:
other details
| description | scientific article published on 27 April 2006 |
External Links
| (P356) |
10.1007/S00280-006-0240-7
|
| (P698) |
16642371
|
| (P5875) |
7139546
|
| (P6179) |
1022538521
|